Literature DB >> 10869846

Immunohistochemical localization of the somatostatin sst(4) receptor in rat brain.

I S Selmer1, M Schindler, P P Humphrey, P C Emson.   

Abstract

The biological actions of the neuromodulator somatostatin are mediated through a family of G-protein-coupled receptors, of which five members, sst(1-5), have been identified. Although the messenger RNA distribution of the sst(4) receptor has been reported, no information about the distribution of the receptor protein in the central nervous system is available. We have therefore raised a polyclonal peptide antibody against a rat carboxy-terminal sst(4) peptide. The selectivity of the affinity-purified antibody was demonstrated by western blotting of membrane proteins isolated from Chinese hamster ovary-K1 cells expressing the recombinant sst(4) receptor and from the rat hippocampus. This resulted in both cases in the identification of a single band of approximately 42,000 mol. wt. Furthermore, the sst(4) receptor antibody selectively labelled Chinese hamster ovary-K1 cells expressing the recombinant sst(4) receptor in immunocytochemistry. No cross-reactivity was observed with other recombinant somatostatin receptors. Immunohistochemistry on adult rat brain sections showed the sst(4) receptor to have a widespread distribution. This included labelling of cell bodies as well as processes in the cerebral cortex, hippocampus and several nuclei in the brainstem. All signals were absent following antibody preabsorption with the synthetic sst(4) peptide. This study provides the first detailed analysis of the distribution of sst(4) receptor protein in the rat brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869846     DOI: 10.1016/s0306-4522(00)00147-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

1.  Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice.

Authors:  Karin Sandoval; David Umbaugh; Austin House; Albert Crider; Ken Witt
Journal:  Neurochem Res       Date:  2019-10-19       Impact factor: 3.996

2.  Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment.

Authors:  William L Neumann; Karin E Sandoval; Shirin Mobayen; Mahsa Minaeian; Stephen G Kukielski; Khush N Srabony; Rafael Frare; Olivia Slater; Susan A Farr; Michael L Niehoff; Audrey Hospital; Maria Kontoyianni; A Michael Crider; Ken A Witt
Journal:  RSC Med Chem       Date:  2021-05-26

3.  Somatostatin increases rat locomotor activity by activating sst(2) and sst (4) receptors in the striatum and via glutamatergic involvement.

Authors:  Stratos Santis; Andreas Kastellakis; Dimitra Kotzamani; Kalliopi Pitarokoili; Despoina Kokona; Kyriaki Thermos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-09-03       Impact factor: 3.000

4.  Activation of somatostatin receptors in the globus pallidus increases rat locomotor activity and dopamine release in the striatum.

Authors:  A Marazioti; P M Pitychoutis; Z Papadopoulou-Daifoti; C Spyraki; K Thermos
Journal:  Psychopharmacology (Berl)       Date:  2008-09-03       Impact factor: 4.530

5.  Immunohistochemical distribution and subcellular localization of the somatostatin receptor subtype 1 (sst1) in the rat hypothalamus.

Authors:  Thomas Stroh; Philippe Sarret; Gloria S Tannenbaum; Alain Beaudet
Journal:  Neurochem Res       Date:  2006-03-02       Impact factor: 3.996

6.  In Silico, In Vitro and In Vivo Pharmacodynamic Characterization of Novel Analgesic Drug Candidate Somatostatin SST4 Receptor Agonists.

Authors:  Boglárka Kántás; Éva Szőke; Rita Börzsei; Péter Bánhegyi; Junaid Asghar; Lina Hudhud; Anita Steib; Ágnes Hunyady; Ádám Horváth; Angéla Kecskés; Éva Borbély; Csaba Hetényi; Gábor Pethő; Erika Pintér; Zsuzsanna Helyes
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

7.  The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain.

Authors:  Priyank A Shenoy; Andy Kuo; Nemat Khan; Louise Gorham; Janet R Nicholson; Laura Corradini; Irina Vetter; Maree T Smith
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

8.  Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain.

Authors:  Boglárka Kántás; Rita Börzsei; Éva Szőke; Péter Bánhegyi; Ádám Horváth; Ágnes Hunyady; Éva Borbély; Csaba Hetényi; Erika Pintér; Zsuzsanna Helyes
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923

9.  Dimethyl Trisulfide Diminishes Traumatic Neuropathic Pain Acting on TRPA1 Receptors in Mice.

Authors:  Ágnes Dombi; Csenge Sánta; István Z Bátai; Viktória Kormos; Angéla Kecskés; Valéria Tékus; Krisztina Pohóczky; Kata Bölcskei; Erika Pintér; Gábor Pozsgai
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.